About us

Lenus Pharma’s success story began in 2006 with its founding by Brigitte Annerl, MSc, and the development of PROFERTIL® for the treatment of male infertility.

In 2007, PROFERTIL® conquered the international market and is now an established partner for couples in more than 70 countries worldwide.

In 2010, Lenus Pharma expanded its portfolio with the launch of PROFERTIL® female. This innovative product aims to support female fertility, providing the perfect complement for couples struggling to conceive.

The consistent focus on couple therapy underscores the goal of offering comprehensive solutions to optimize the chances of pregnancy with PROFERTIL® and PROFERTIL® female.

The commitment to women’s health was further strengthened in 2016 with the introduction of Menopearl®. This innovative combination of isoflavones and hyaluronic acid addresses the specific needs of women during menopause.

In 2023, the range was extended with PROFERTIL® Inositol for the treatment of PCOS (polycystic ovary syndrome). Thanks to its innovative easy-to-go format, the product can be taken without water.

In addition to products for treating infertility and menopausal complaints, Lenus Pharma exclusively offers the PROMACULA® product line in Austria, developed to support age-related macular degeneration.

The driving force behind Lenus Pharma is the mission to develop innovative products for medical needs. Providing evidence-based solutions is the highest priority—the company’s “holy grail,” as founder Brigitte Annerl, MSc, emphasizes.

Lenus Pharma stands for scientifically grounded innovation in the service of health.

Our goal at Lenus Pharma is to offer clinically proven innovations and make them accessible to patients around the world.

“Giving life – preserving life”